Risk of Reduced Benefits Due to Revisions to the Long-Term Care Insurance System
First written in FY2018-Q3. 2 of 11 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Our group’s sales dependent on the long-term care insurance system totaled ¥2,535.155 million, comprising ¥2,256.136 million in sales from the Sales Division serving nursing-care product and wholesale businesses, among others, and ¥279.018 million from the nursing-care services business, accounting for 39.6% of total sales.」
The ratio of sales dependent on the long-term care insurance system has declined from 42.31% previously stated to 39.6%. The risk of changes in demand resulting from changes to the system continues to be disclosed. - FY2026-H1RestatedAnnual report
「In addition, following the April 2025 revisions to long-term care fees and amendments to related laws and systems, ensuring management transparency and efficiency has become an important management issue.」
The revisions to long-term care fees and amendments to related laws and systems are described as part of the business environment, but the document states that there have been no significant changes in business and other risks. - FY2024WorsenedAnnual report
「Our group’s sales dependent on the long-term care insurance system totaled ¥2,709.536 million, comprising ¥2,558.046 million in sales from the Sales Division serving nursing-care product and wholesale businesses, among others, and ¥151.489 million from the nursing-care services business, accounting for 42.31% of total sales.」
The ratio of sales dependent on the long-term care insurance system has increased from the previously stated 40.9% to 42.31%. The risk of changes in demand resulting from changes to the system continues to be disclosed. - FY2022Increase in dependence on long-term care insuranceAnnual report
「Our group’s sales dependent on the long-term care insurance system totaled ¥2,339.757 million, comprising ¥2,152.608 million in sales from the Sales Division serving nursing-care product and wholesale businesses, among others, and ¥187.148 million from the nursing-care services business, accounting for 40.9% of total sales.」
The risk of changes to the long-term care insurance system continues to be disclosed, with sales dependent on the system updated to ¥2,339.757 million, or 40.9% of total sales. - FY2020Update to the ratio of long-term care insurance-related salesAnnual report
「Sales in our Sales Division, which serves nursing-care product and wholesale businesses, among others, amounted to ¥1,756.056 million in the fiscal year ended February 2020, accounting for 29.3% of total sales. In addition, because nursing-care services have been added to our group’s business activities, revisions to long-term care fees every 3 years could affect earnings.」
The risk of changes to the long-term care insurance system continues to be disclosed, with related sales updated to ¥1,756 million, or 29.3% of total sales. The risk of revisions to long-term care fees associated with the nursing-care services business also continues. - FY2020-Q3Update to the ratio of long-term care insurance-related salesAnnual report
「Sales in our Sales Division 2, which serves nursing-care product and wholesale businesses, among others, amounted to ¥1,388 million in the third quarter of the fiscal year ending February 2020, accounting for 28.9% of total sales. Accordingly, changes in demand resulting from changes in the scope of insured persons certified as requiring long-term care, the scope of assistive products covered by long-term care insurance, or users’ co-payment rates could affect the operating results and financial condition of our group.」
The risk of changes to the long-term care insurance system continues to be disclosed, with long-term care insurance-related sales updated to ¥1,388 million, or 28.9% of total sales. The risk of revisions to long-term care fees related to the day-care services business also continues. - FY2020-Q2Update to the ratio of long-term care insurance-related salesAnnual report
「Sales in our Sales Division 2, which serves nursing-care product and wholesale businesses, among others, amounted to ¥987 million in the second quarter of the fiscal year ending February 2020, accounting for 28.8% of total sales. Accordingly, changes in demand resulting from changes in the scope of insured persons certified as requiring long-term care, the scope of assistive products covered by long-term care insurance, or users’ co-payment rates could affect the operating results and financial condition of our group.」
The risk of changes to the long-term care insurance system continues to be disclosed, with long-term care insurance-related sales updated to ¥987 million, or 28.8% of total sales. The risk of revisions to long-term care fees related to the day-care services business also continues to be disclosed. - FY2020-Q1Risk of revisions to long-term care fees following the addition of the day-care services businessAnnual report
「In addition, because day-care services have been added to our group’s business activities, revisions to long-term care fees every 3 years could affect earnings. Although day-care services currently account for only a small proportion of our group’s total sales, a higher proportion in the future could affect the operating results and financial condition of our group.」
In addition to the previously stated risks related to changes in long-term care insurance benefits and co-payment rates, the document now describes the risk of revisions to long-term care fees every 3 years following the addition of the day-care services business. Sales to nursing-care product and wholesale businesses are stated at ¥574 million, representing 31.9% of total sales. - FY2019Decline in the ratio of long-term care insurance-related salesAnnual report
「Sales in our Sales Division 2, which serves nursing-care product and wholesale businesses, among others, amounted to ¥1,630 million in the fiscal year ended February 2019, accounting for 36.0% of total sales. Accordingly, changes in demand resulting from changes in the scope of insured persons certified as requiring long-term care, the scope of assistive products covered by long-term care insurance, or users’ co-payment rates could affect the operating results and financial condition of our group.」
The risk of changes to the long-term care insurance system continues to be disclosed. The ratio of long-term care insurance-related sales has declined from 44.9% to 36.0%. - FY2018RestatedAnnual report
「Sales in our Sales Division 2, which serves nursing-care product and wholesale businesses, among others, amounted to ¥2,287 million in the fiscal year ended February 2018, accounting for 44.9% of total sales. Accordingly, changes in demand resulting from changes in the scope of insured persons certified as requiring long-term care, the scope of assistive products covered by long-term care insurance, or users’ co-payment rates could affect the operating results and financial condition of our group.」
The document continues to state that the proposal to reduce benefits was not adopted and that demand is recovering, while quantifying the group’s dependence on long-term care insurance-related sales at 44.9%. - FY2018-Q3First statedAnnual report
「Regarding the long-term care insurance system to be amended for the fiscal year ending March 2019, the proposal submitted by the Fiscal System Council to the Long-Term Care Insurance Subcommittee of the Social Security Council, which met in December 2016, to substantially reduce the insurance benefit coverage rate, mainly for persons requiring light care (Care Level 2 or below), was not adopted, and demand for businesses that rent and sell assistive products for nursing care is beginning to recover.」
The proposal to substantially reduce the benefit coverage rate for persons at Care Level 2 or below was identified as a risk factor, but this filing states that the proposal was not adopted.